ARCHIVES OF MEDICAL RESEARCH, cilt.47, sa.7, ss.506-514, 2016 (SCI-Expanded)
Background and Aims. Anthracyclines are one of the most preferred agents in practical pediatric oncology despite their dose-dependent cardiotoxic effects. The aim of this study was to investigate whether or not acetyl-L-carnitine (ALCAR) has protective effects on doxorubicin (DOX)-induced cardiotoxicity.